Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/2012
06/26/2012US8207234 Methods for treating diabetic foot ulcers
06/26/2012US8207233 Methods for treating diabetic foot ulcers
06/26/2012US8207131 Peptide
06/26/2012US8207128 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
06/26/2012US8207119 Ophthalmological composition
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012CA2508129C Novel x-conotoxin peptides (-i)
06/26/2012CA2484594C Process for the synthesis of peptides
06/26/2012CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes
06/26/2012CA2425602C Methods of high-throughput screening for internalizing antibodies
06/26/2012CA2270448C Method for giving resistance to weed control compounds to plants
06/26/2012CA2263895C Therapeutic and diagnostic applications of perlecan domain i splice variants
06/21/2012WO2012083078A2 Croos-linked peptides and proteins, methods of making same, and uses thereof
06/21/2012WO2012081531A1 Disease inhibiting agent
06/21/2012WO2012080929A2 Use of ide as a biomarker for a scalp condition
06/21/2012WO2012079488A1 P28gank monoclonal antibody and peptides for preparation thereof and use thereof
06/21/2012WO2012079172A1 Cyclosporine analogue molecules modified at amino acid 1 and 3
06/21/2012WO2012079125A1 Designed biosurfactants, their manufacture, purification and use
06/21/2012WO2012061113A3 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
06/21/2012WO2012031228A3 Llp2a-bisphosphonate conjugates for osteoporosis treatment
06/21/2012US20120157660 Novel peptides that bind to the erythropoietin receptor
06/21/2012US20120157659 Affinity peptides and method for purification of recombinant proteins
06/21/2012US20120157389 Peptides for treating cancer
06/21/2012US20120157385 Cyclosporin conjugates
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157376 Pharmacologically active antiviral peptides and methods of their use
06/21/2012US20120157372 Human milk peptides
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156704 In vitro method for detecting gp91phox as a marker of oxidative stress
06/21/2012US20120156295 Antibiotic compounds
06/21/2012US20120156276 Connective tissue stimulating peptides
06/21/2012US20120156242 An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody
06/21/2012US20120156236 Neisseria meningitidis antigens and compositions
06/21/2012US20120156234 Means for treating synucleinopathies
06/21/2012US20120156233 Vaccine therapy for choroidal neovascularization
06/21/2012US20120156231 Foxm1 peptides and vaccines containing the same
06/21/2012US20120156215 Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications
06/21/2012US20120156180 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
06/21/2012US20120156173 Fusarium and other pathogenic fungi and mycotoxin biocontrol
06/21/2012US20120156134 Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
06/21/2012CA2821022A1 A monoclonal antibody against p28gank, the polypeptide used to prepare this antibody and their applications
06/21/2012CA2821009A1 Cyclosporine analogue molecules modified at amino acid 1 and 3
06/21/2012CA2820871A1 Disease inhibiting agent
06/20/2012EP2465522A1 Chemerin-15h and its use for treatment of inflammation and endotoxic shock
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2464656A1 Novel peptide and use thereof
06/20/2012EP2464655A1 Chromatographic processes and purified compounds thereof
06/20/2012EP2464374A1 Separation and/or purification of pneumocandin b0 from c0
06/20/2012EP2073829B1 Stabilized therapeutic small helical antiviral peptides
06/20/2012CN102504016A Amyloid fibrillar oligomer conformational epitope polypeptide and application thereof
06/20/2012CN102504015A Cardiovascular targeted small peptide MI-1 and application thereof
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN101724023B Restricted epitope peptide of antigen of mycobacterium tuberculosis
06/19/2012US8202973 Method for the production of vitamin K-dependent proteins
06/19/2012US8202969 Platelet derived growth factor receptor alpha (PDGFRA) polypeptides comprising activating mutation(s)
06/19/2012US8202841 SSX-2 peptide analogs
06/19/2012US8202838 Methods for treatment of headaches by administration of oxytocin
06/14/2012WO2012078760A1 Self-assembling hydrogels based on dicephalic peptide amphiphiles
06/14/2012WO2012078734A2 Polypeptide derived from calcitonin receptors and methods of use
06/14/2012WO2012078116A1 Immunogenic chikungunya virus peptides
06/14/2012WO2012077037A2 PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2
06/14/2012WO2012076822A1 Peptides and antiviral drug
06/14/2012WO2012075570A1 Bioactive peptides and proteins containing bioactive peptides, their uses and processes for making the same
06/14/2012WO2012035310A3 Therapeutic conjugates of a dextrin polymer and an antimicrobial peptide
06/14/2012WO2011149310A9 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
06/14/2012WO2011088462A3 Alpha-fetoprotein 'ring and tail' peptides
06/14/2012US20120151636 Peptides for Stimulating Plant Disease Resistance
06/14/2012US20120149869 Alpha-conotoxin peptides
06/14/2012US20120149651 Caveolin peptides and their use as therapeutics
06/14/2012US20120149649 Short-chain cationic polyamino acid and use thereof
06/14/2012US20120149640 Peptides modulating the activity of igf-1 and the applications of said peptides
06/14/2012US20120149634 Compounds and methods for treating bone disorders and controlling weight
06/14/2012US20120149633 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom
06/14/2012US20120149631 Antimicrobial and antibiofilm activity of cathelicidins
06/14/2012US20120149130 Polypeptides for the in vitro assessment of the sensitising potential of a test compound
06/14/2012US20120149062 High Purity Lipopeptides
06/14/2012US20120149053 Carrier peptide fragment and use thereof
06/14/2012US20120149038 Diagnosis of autism
06/14/2012US20120149034 Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
06/14/2012US20120148681 Peptides and peptide compositions having osteoinductive activity
06/14/2012US20120148674 Self-assembling hydrogels based on dicephalic peptide amphiphiles
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148575 Methods Of Reducing Eosinophil Levels
06/14/2012US20120148499 Peptides and aptamers for targeting of neuron or nerves
06/14/2012US20120144956 Metal Nanoparticles with a Pre-Selected Number of Atoms
06/13/2012EP2463299A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
06/13/2012EP2463293A1 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof
06/13/2012EP2462155A1 Novel antipathogenic peptides
06/13/2012EP2407479A9 Self-assembling peptide and peptide gel with high strength
06/13/2012EP2399927A9 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
06/13/2012EP1699460B1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1480666B1 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
06/13/2012CN102498124A Cyclic amino acid molecules and methods of preparing the same
06/13/2012CN102492689A Preparation method for novel food preservative antibacterial peptide
06/13/2012CN102492025A Micro-molecular peptide with insecticidal activity
06/13/2012CN102492024A Method for extracting daptomycin from fermentation broth
06/13/2012CN102492023A PLAC1 anti-tumour CTL epitope peptide and application thereof
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 423